tiprankstipranks
Advertisement
Advertisement

Zynex Files Amended Chapter 11 Reorganization Plan

Story Highlights
  • Zynex filed Chapter 11 in December 2025 and later submitted an amended reorganization plan.
  • The plan adds a global settlement, creates a creditor trust, and warns equity holders of likely losses.
  • Looking for the best stocks to buy? Follow the recommendations of top-performing analysts.
Zynex Files Amended Chapter 11 Reorganization Plan

Claim 30% Off TipRanks

The latest announcement is out from Zynex ( (ZYXIQ) ).

On December 15, 2025, Zynex, Inc. and certain subsidiaries filed voluntary Chapter 11 petitions in the U.S. Bankruptcy Court for the Southern District of Texas, and on February 1, 2026, the company submitted a Second Amended Combined Disclosure Statement and Joint Plan of Reorganization consistent with a previously agreed Restructuring Support Agreement. The amended plan introduces a global settlement with an ad hoc noteholder group and the official committee of unsecured creditors, establishes a trust funded with $750,000, D&O insurance policies and certain estate claims for holders of allowed convertible notes and general unsecured claims, provides for an equity transaction with a plan sponsor via a parallel sale process, and warns that trading in Zynex’s securities during the Chapter 11 process is highly speculative, with equity holders expected to suffer significant losses if the restructuring is implemented.

The most recent analyst rating on (ZYXIQ) stock is a Sell with a $0.05 price target. To see the full list of analyst forecasts on Zynex stock, see the ZYXIQ Stock Forecast page.

Spark’s Take on ZYXIQ Stock

According to Spark, TipRanks’ AI Analyst, ZYXIQ is a Underperform.

The score is driven primarily by weak financial performance (revenue collapse, losses, negative equity, and negative operating cash flow) and a strongly bearish technical setup. Earnings-call details and corporate events add elevated restructuring/legal risk (Chapter 11 and executive indictment), while valuation is difficult to support due to a negative P/E and no dividend.

To see Spark’s full report on ZYXIQ stock, click here.

More about Zynex

Zynex, Inc. operates in the United States healthcare sector, with its business significant enough to involve multiple subsidiaries and public securities, including convertible notes and general unsecured claims held by a broad creditor base.

Average Trading Volume: 6,143,227

Technical Sentiment Signal: Sell

Current Market Cap: $1.68M

For detailed information about ZYXIQ stock, go to TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1